San Diego, CA, United States of America

Porino Jinjo Va

This inventor holds 6 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Xinthera, Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Porino Jinjo Va. Retrieved from https://idiyas.com/inventor/porino-jinjo-va

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 6 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 5.3

ph-index = 2

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Porino Jinjo Va: Innovator in Cancer Treatment

Introduction

Porino Jinjo Va is a prominent inventor based in San Diego, CA, known for his significant contributions to the field of cancer treatment. With a total of six patents to his name, he has made remarkable strides in developing innovative pharmaceutical compositions.

Latest Patents

His latest patents include "Substituted pyridines as PARP1 inhibitors," which describes tricyclic PARP1 inhibitors and pharmaceutical compositions that are useful for treating cancer. Another notable patent is "PARP1 inhibitors and uses thereof," which also focuses on PARP1 inhibitors and their applications in cancer treatment.

Career Highlights

Porino Jinjo Va is currently associated with Xinthera, Inc., where he continues to advance his research and development efforts. His work has been instrumental in creating effective treatments that target cancer at the molecular level.

Collaborations

Some of his notable coworkers include Robert L Hoffman and Qing Dong, who contribute to the innovative environment at Xinthera, Inc.

Conclusion

Porino Jinjo Va's work exemplifies the impact of innovation in the medical field, particularly in the fight against cancer. His patents reflect a commitment to improving patient outcomes through advanced therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…